NCT03778333View on ClinicalTrials.gov

Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 1, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Autologous Mesenchymal Stem CellsMultiple Sclerosis
Interventions
BIOLOGICAL

Autologous mesenchymal stem cells

IV therapy with autologous bone-marrow derived mesenchymal stem cells

Trial Locations (2)

17176

Karolinska Institute, Karolinska University Hospital, Stockholm

171 76

Karolinska Institute, Karolinska University Hospital Solna, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT03778333 - Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden | Biotech Hunter | Biotech Hunter